Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Eli Lilly

Eli Lilly Wins Long-Awaited Approval For Biogen-Rivaling Alzheimer's Drug

Eli Lilly won FDA approval for its Alzheimer's treatment, donanemab, on Tuesday. But Eli Lilly stock remained in the red.

Investors Business Daily

Novo, Lilly Fall After Biden Slams Duo For 'Unconscionably High' Drug Prices

Novo, Lilly Fall After Biden Slams Duo For 'Unconscionably High' Drug Prices

Novo Nordisk stock fell Tuesday after Joe Biden and Bernie Sanders slammed the drugmaker and Eli Lilly for high prices of weight-loss drugs.

Investors Business Daily

Biden Calls For Lower Prices Of Ozempic, Similar Drugs

Biden Calls For Lower Prices Of Ozempic, Similar Drugs

US President Joe Biden on Tuesday called on pharmaceutical giants Novo Nordisk and Eli Lilly to lower prices for diabetes and weight loss drugs such as Ozempic, saying firms must stop "ripping off the American people."

International Business Times

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Nvidia Among Biggest Stock Market Winners In 2024, But This Is No. 1

Nvidia has more than doubled so far this year, but the biggest S&P 500 stock winner is Super Micro, one of several big AI performers.

Investors Business Daily

3 Mega-Cap Stocks to Consider Before They're Worth $1 Trillion

Mega-cap stocks are the flavor of the season, and these three big names are the next set of contenders racing towards the $1 trillion market cap club.

Eli Lilly Option Trade Could Make $4,000 With A Pullback

This broken wing butterfly trade has a profit zone between 810 and 890.

Investors Business Daily

Chart of the Day: Eli Lilly - More New Highs

Author's Note: Last featured 10/26/23 at $586.37. Gained 54% since that date. The Chart of the Day belongs to the drug manufacturer Eli Lilly (LLY) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current...

inkl

Read news from The Economist, FT, and more,
with one subscription

Novo Nordisk’s Wegovy may just have two years to take over China’s market for weight loss drugs

Novo Nordisk’s Wegovy may just have two years to take over China’s market for weight loss drugs

Novo Nordisk's China patent on Wegovy's active ingredient expires in 2026, much earlier than its patents in the U.S., Japan and Europe.

Ozempic maker Novo Nordisk invests $4bn to meet US ‘skinny jab’ demand

Ozempic maker Novo Nordisk invests $4bn to meet US ‘skinny jab’ demand

Pharma group plans plant in North Carolina to produce diabetes drug and weight-loss product Wegovy

The Guardian - UK

Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again

Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again

ResMed stock and Inspire Medical Systems stock tumbled Monday after Eli Lilly said its weight-loss drug reduced sleep apnea events.

Investors Business Daily

Lawsuit could challenge trust in Ozempic and other popular weight loss drugs

Lawsuit could challenge trust in Ozempic and other popular weight loss drugs

The manufacturers of the most popular weight loss drugs are being challenged in court.

The Conversation

Top Weight-Loss Rivals Share This Risk After Eye-Popping Runs

Top Weight-Loss Rivals Share This Risk After Eye-Popping Runs

Popular weight-loss drugs have boosted Novo Nordisk and Eli Lilly. After huge gains, the drugmakers' stocks now face this risk.

Investors Business Daily

Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar

Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar

Gilead stock jumped Friday after surprising Wall Street with preclinical test results for an under-the-radar weight-loss drug.

Investors Business Daily

Stock Market Hits Highs; Tame Inflation, Fed Meeting, Apple, Broadcom, Oracle, Tesla: Weekly Review

Stock Market Hits Highs; Tame Inflation, Fed Meeting, Apple, Broadcom, Oracle, Tesla: Weekly Review

The Nasdaq and S&P 500 hit record highs on tame inflation and as Apple, Broadcom and Oracle soared on news. But the stock market gains were narrow.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Fidelity And T. Rowe Price Score Big On These 'New' Blue Chips

Both Fidelity and T. Rowe Price ETFs are both cashing in on "blue chips." But these aren't the S&P 500 blue chips of yore you might think of.

Investors Business Daily

Eli Lilly Seesaws On FDA Win, And Pushes Alzheimer's Stocks Prothena, Eisai Lower

Eli Lilly stock seesawed Tuesday after a Food and Drug Administration panel endorsed its Alzheimer's treatment, donanemab.

3 Stocks Most Likely to Join the $1 Trillion Market Cap Club in the Next 5 Years

With a solid product portfolio, brand strength, and a thirst for innovation, these three companies are on the right track.

The Independent UK

Alzheimer's drug that can slow disease gets backing from FDA advisers

Federal health advisers have endorsed a closely watched Alzheimer’s drug from Eli Lilly for people with mild dementia

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

FDA Panelists Unanimously Back Eli Lilly's Biogen-Rivaling Alzheimer's Drug

Eli Lilly stock jumped Monday after FDA advisors said the benefits of Alzheimer's treatment donanemab outweigh the risks for most patients.

Investors Business Daily

Dow Jones Futures Fall; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

The stock market is at highs with Apple's AI push, the Fed rate "dot-plot" and the Tesla shareholder meeting headlining key events and news.

Structure Therapeutics vs. Viking Therapeutics: Which Weight-Loss Drug Stock Wins?

With weight-loss drugs gaining traction, which biopharma stock wins?

Eli Lilly Stock: Is LLY Outperforming the Healthcare Sector?

Eli Lilly has outperformed the healthcare sector over the past three months, but analysts remain cautiously optimistic about the stock’s prospects.

In China, weight-loss drugs are becoming big business

Chinese pharmaceutical companies are racing to roll out weight-loss drugs amid the popularity of Ozempic.

Investors Business Daily

Mutual Funds Keep Buying Up Google, These 2 Other Big Caps

Google stock is a mutual fund favorite and is near a buy point. Two other leading growth stocks top the list of fund favorites.

Investors Business Daily

Madrigal, 89bio Tumble After Lilly's Weight-Loss Drug Tackles MASH

Madrigal stock plummeted Wednesday on detailed results from a study of Eli Lilly's weight-loss drug in patients with a serious liver disease.

1 … 9 10 11 12

People

Todd Rosenbluth

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

261,307 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play